Gilder Gagnon Howe & Co’s Medicines Co MDCO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,100	Closed	-$155K	–	316
2019 Q3	$155K	Buy	+3,100	New	+$124K	﹤0.01%	266

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Gilder Gagnon Howe & Co's MDCO Position: Q4 2019 in Review

Gilder Gagnon Howe & Co sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 3,100 shares — an estimated $155K sold.

Gilder Gagnon Howe & Co first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $155K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Gilder Gagnon Howe & Co reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 3,100 Medicines Co shares in Q4 2019, an estimated $155K.
Gilder Gagnon Howe & Co first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
Gilder Gagnon Howe & Co's Medicines Co position peaked at $155K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2019, filed 14 Feb 2020.